E Hapolo1, J Ilai1, T Francis1, P du Cros2, M Taune1, G Chan2. 1. Daru General Hospital, Daru, Western Province, Papua New Guinea. 2. Burnet Institute, Melbourne, Victoria, Australia.
Abstract
SETTING: Daru General Hospital, Daru Island, Papua New Guinea, where high rates of tuberculosis (TB) have been reported. Prompt diagnosis and effective treatment are needed for improving TB outcomes and to prevent nosocomial transmission. OBJECTIVE: To assess the time to treatment initiation and the risk factors associated with delayed treatment for patients started on TB treatment at Daru General Hospital from January to September 2017. DESIGN: This was a retrospective cohort study that entailed reviewing the records from treatment, admission, discharge and presumptive TB registers. RESULTS: The study included 360 patients on TB treatment. The median time from presentation to treatment initiation was 7 days [IQR 3-11]. Treatment was started <7 days for 215 patients (60%); however, only 16.2% commenced treatment <2 days. Risk factors for delayed treatment were diagnosis of TB as an inpatient (OR 2.67, 95% CI 1.35-5.28, P = 0.005) and having drug-resistant TB (OR 2.65, 95% CI 1.5-4.68. P = 0.001). CONCLUSION: A high proportion of TB patients commenced treatment <7 days. Inpatient status, DR-TB and lack of microbiological confirmation were associated with delays in treatment initiation. We recommend that programmes monitor the time from presentation to treatment initiation, and propose that a period of >3 days from presentation to treatment initiation be considered as delayed treatment initiation.
SETTING: Daru General Hospital, Daru Island, Papua New Guinea, where high rates of tuberculosis (TB) have been reported. Prompt diagnosis and effective treatment are needed for improving TB outcomes and to prevent nosocomial transmission. OBJECTIVE: To assess the time to treatment initiation and the risk factors associated with delayed treatment for patients started on TB treatment at Daru General Hospital from January to September 2017. DESIGN: This was a retrospective cohort study that entailed reviewing the records from treatment, admission, discharge and presumptive TB registers. RESULTS: The study included 360 patients on TB treatment. The median time from presentation to treatment initiation was 7 days [IQR 3-11]. Treatment was started <7 days for 215 patients (60%); however, only 16.2% commenced treatment <2 days. Risk factors for delayed treatment were diagnosis of TB as an inpatient (OR 2.67, 95% CI 1.35-5.28, P = 0.005) and having drug-resistant TB (OR 2.65, 95% CI 1.5-4.68. P = 0.001). CONCLUSION: A high proportion of TB patients commenced treatment <7 days. Inpatient status, DR-TB and lack of microbiological confirmation were associated with delays in treatment initiation. We recommend that programmes monitor the time from presentation to treatment initiation, and propose that a period of >3 days from presentation to treatment initiation be considered as delayed treatment initiation.
Authors: Richard J Lessells; Graham S Cooke; Nuala McGrath; Mark P Nicol; Marie-Louise Newell; Peter Godfrey-Faussett Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar Journal: Public Health Action Date: 2018-06-21
Authors: Lyndsay M O'Hara; Annalee Yassi; Muzimkhulu Zungu; Molebogeng Malotle; Elizabeth A Bryce; Stephen J Barker; Lincoln Darwin; J Mark FitzGerald Journal: BMC Infect Dis Date: 2017-08-07 Impact factor: 3.090
Authors: Ye Minn Htun; Tin Mi Mi Khaing; Yin Yin; Zaw Myint; Si Thu Aung; Tin Maung Hlaing; Ngamphol Soonthornworasiri; Udomsak Silachamroon; Yuthichai Kasetjaroen; Jaranit Kaewkungwal Journal: BMC Health Serv Res Date: 2018-11-20 Impact factor: 2.655